CLINICAL TOXICOLOGY is a prestigious journal dedicated to advancing the field of toxicology, published by Taylor & Francis Ltd. With ISSN 1556-3650 and E-ISSN 1556-9519, it has been a vital resource for researchers, clinicians, and students since its inception in 1968. The journal is recognized for its high impact, boasting a Q1 quartile ranking in both the categories of Medicine (miscellaneous) and Toxicology as of 2023, reflecting its reputation for disseminating significant contributions to the field. CLINICAL TOXICOLOGY primarily features original research, reviews, and case reports that explore the latest advancements and methodologies in the diagnosis and management of toxic exposures, making it an essential tool for professionals seeking to stay abreast of current trends and best practices. The journal's open access options ensure that its content is readily available to a wide audience, thereby promoting the exchange of knowledge and collaborative efforts within the global scientific community. For those committed to improving public health outcomes through toxicological research, CLINICAL TOXICOLOGY provides an indispensable platform for publication and discourse.

Exposure and Health is a pioneering journal published by Springer, specializing in the interdisciplinary fields of health, toxicology, and environmental sciences. With an ISSN of 2451-9766 and E-ISSN of 2451-9685, this open-access journal exemplifies a commitment to disseminating high-quality research that informs public health practices and policies globally. Situated in the Netherlands, it boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple categories in the 2023 Scopus rankings, including Health, Toxicology and Mutagenesis, Pollution, and Water Science and Technology. The journal is dedicated to advancing knowledge on the interactions between environmental factors and health outcomes, making it a vital resource for researchers, professionals, and students in these critical fields. Exposure and Health actively encourages submissions that address the challenges of exposure assessment, risk management, and the promotion of sustainable public health initiatives.

The University of Toronto Medical Journal is a prominent publication within the field of General Medicine, dedicated to the dissemination of innovative research and critical discourse relevant to the medical community. Established in 1945 and published by the University of Toronto Medical Society, this journal serves as a platform for medical students and professionals to share their insights, fostering an environment of learning and collaboration. Over the years, the journal has played a crucial role in nurturing future leaders in medicine, contributing significantly to the academic landscape, despite its current Scopus rank of #511 out of 636 in its category, reflecting its niche yet vital presence. With an ISSN of 0833-2207 and an E-ISSN of 1913-5440, the journal remains a reference point for those passionate about medical research and education in Canada and beyond. Although it does not operate under an open-access model, the journal’s commitment to academic rigor and integrity continues to make it an essential resource for students, researchers, and healthcare professionals alike.

International Journal of Medical Toxicology and Forensic Medicine, published by Shaheed Beheshti Medical University of Medical Sciences & Health Services, is a pioneering platform dedicated to advancing knowledge within the critical fields of toxicology and forensic medicine. Established as an Open Access journal since 2011, it ensures wide dissemination of research findings, catering to a global audience of researchers, healthcare professionals, and students. With an ISSN of 2251-8762 and an E-ISSN of 2251-8770, the journal covers a diverse range of topics relevant to the medical community, albeit being categorized as Q4 in both Pathology and Forensic Medicine and Toxicology in 2023, indicating emerging significance in these disciplines. Geographically based in Tehran, Iran, it aspires to bridge gaps in scientific research and practice, particularly in regions where such expertise is critical. The journal welcomes submissions that investigate pressing issues in medical toxicology and forensic science, fostering an interdisciplinary dialogue essential for innovative solutions and improved public health outcomes.

Bangladesh Journal of Medical Science, published by IBN SINA TRUST, is a prominent open access journal dedicated to the dissemination of innovative research in the field of medicine. Since its inception in 2009, this journal has aimed to bridge the gap in medical knowledge, focusing on a diverse array of sub-disciplines within the field, thus extending its relevance to both local and international audiences. With an ISSN of 2223-4721 and E-ISSN 2076-0299, it has gained recognition in the academic community, evidenced by its Q3 category rank in Medical (Miscellaneous) and a notable placement in the 58th percentile of general medicine according to Scopus rankings. The journal accepts original research articles, reviews, and case reports, making it a vital resource for researchers, professionals, and students alike. With an objective to provide open access to high-quality medical science literature, the Bangladesh Journal of Medical Science fosters an environment of scholarly exchange, contributing to the ongoing advancement of healthcare practices and medical education in Bangladesh and beyond.

Kuwait Medical Journal is a prominent scholarly publication dedicated to advancing medical knowledge and practice in the Gulf region and beyond. Published by the Kuwait Medical Association, this journal has been a crucial platform for disseminating research findings since its inception in 1973. Despite its discontinuation in Scopus coverage after 1990, it remains significant within the Q4 category in Medicine (miscellaneous), serving as a valuable resource for healthcare professionals, researchers, and students alike. The journal is based in Kuwait and aims to foster academic dialogue by featuring original research articles, reviews, and case studies that highlight the evolving landscape of medical science and practice. While currently not an open-access platform, the Kuwait Medical Journal continues to uphold the integrity and quality of medical research, contributing to the broader discourse in healthcare.

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

Welcome to the Italian Journal of Medicine, a distinguished publication in the realm of medical research and practice, diligently published by PAGEPRESS PUBL since 2007. This journal serves as a vital platform for the dissemination of innovative research findings, clinical studies, and reviews, providing an essential resource for researchers, healthcare professionals, and medical students alike. With an ISSN of 1877-9344 and an E-ISSN of 1877-9352, the journal embraces an Open Access model, ensuring that knowledge is accessible to all and promoting collaboration across the global medical community. While it currently holds a Q4 ranking in the miscellaneous category of medicine and a respectable rank of #372 out of 636 in General Medicine according to Scopus metrics, the Italian Journal of Medicine remains committed to improving its impact and reach in the scientific landscape. Situated in Pavia, Italy, the journal aims to bridge the gap between research and practice, fostering advancements that ultimately enhance patient care.

YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.